Global Patient Return Electrodes Market - 2023-2030
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
発行: DataM Intelligence
ページ情報: 英文 182 Pages
心臓血管手術の増加は、今後数年間の世界市場の成長を促進すると予想されます。英国心臓財団の2022年1月の更新によると、2021年11月末までに284,000人近くが一刻を争う心臓手術やその他の心臓処置を待っています。患者用対極板は心血管手術で使用されるため、予測期間中の世界市場の成長を後押しすると予想されます。さらに、Lifespan Health Systemの報告によると、米国では年間50万件以上の開心術が行われており、これには大動脈や心臓自体の複雑な手術、冠動脈バイパスなどが含まれます。
製品リコールは、予測期間中の世界市場の成長を妨げると予想されます。例えば、米国食品医薬品局（FDA）は6月1日、メガダイン（J&Jエチコンブランド）のMEGA 2000およびMEGA softの再使用型患者用対極板のリコールをクラスIに分類しました。さらに、他の要因に関連した問題も世界市場の成長を妨げています。
Patient return electrodes are also referred to as passive/plate electrodes, circuit plates, grounding electrodes(pad), and dispersive electrodes. Its broad surface decreases current density, safely stems current via the patient's body during electrosurgery, and averts burns. This electrode plate can signal the system to enhance safety without being completely connected to the patient. The conductive cover is constructed from aluminum, which has low resistance and is non-toxic, non-sensitizing, and non-irritating to the skin.
The increasing number of cardiovascular surgeries is expected to drive the global market growth in the coming years. According to the British Heart Foundation's January 2022 update, nearly 284,000 people were waiting for time-sensitive heart operations and other heart procedures by the end of November 2021. Since patient return electrodes are used in cardiovascular surgeries, this is expected to boost the global market growth during the forecast period. Additionally, the Lifespan Health System reports that over 500,000 open heart procedures are performed annually in the United States, including complex procedures for the aorta or the heart itself, and coronary artery bypass.
Moreover, the rising prevalence of other chronic conditions such as cancer, diabetes, and neurological disorders among others is also expected to contribute to the global market growth during the forecast period.
The market product recalls are expected to hamper the global market growth during the forecast period. For instance, the U.S. Food and Drug Administration (FDA) has classified Megadyne's (a J&J Ethicon brand) recall of MEGA 2000 and MEGA soft reusable patient return electrodes on June 1 as Class I. The recall affects 21,200 devices that were distributed between March 11, 2021, and May 9, 2023, in the United States. Further, problems associated with the product among other factors are also hampering the global market growth.
The global patient return electrodes market is segmented based on type, application, end user and region.
Electrotherapy is utilized for the treatment of neurological, muscular, or muscle-nerve conditions that induce pain. Electrotherapy can be advantageous in individuals encountering extreme sensitivity, numbness, or defects in back muscles. The growing cases of neurological, muscular, or muscle-nerve conditions are expected to boost the segment growth thereby dominating the global market during the forecast period. For instance, according to the National Safety Council of the United States in 2021, it is assessed that approximately 3.2 million individuals were treated in emergency units for injuries concerning sports and recreational tools in the United States in 2021.
Moreover, according to the Alzheimer's Association Alzheimer's Disease Facts and Figures 2022, Alzheimer's is additionally predominant in individuals past 65 years of age. Further, the WHO data also informed that the number would surpass 82 million by 2030. This growing load of nervous system diseases is expected to propel the demand for electrotherapy.
The North American market for patient return electrode is expected to dominate the global market during the forecast period owing to the increase in ambulatory surgeries and surgical centers. For instance, in the US, six out of ten adults suffer from chronic conditions, according to the Centers for Disease Control and Prevention (CDC), with the increasing number of ambulatory surgery centers, there is likely to be a greater number of open surgeries, which will in turn increase the demand for devices used for open procedures including patient return electrodes. Additionally, there has been a 2.1% increase in the number of Ambulatory Surgery Centers enterprises in the US as of 2023, with the number of firms expected to continue to rise.
Further, the presence of key market players holding majority of market share, growing awareness regarding chronic conditions and investments are also expected to contribute to the regional market growth during the forecast period.
The global market for patient return electrodes has been negatively impacted by the COVID-19 pandemic. During the outbreak, a large number of elective surgeries were either suspended or terminated, which led to a decrease in demand for these devices. For example, in order to optimize resources and address the unique needs of both the general population and healthcare systems, the FIGO and Minimal Access Surgery (MAS) board recommended suspending elective and non-urgent surgeries based on the health needs of each country and the response capacity of each healthcare system.
The major global players in the market include: Medtronic, CONMED Corporation, Ethicon, Inc., Bowa-Electronic Gmbh & Co. Kg, 3m, Erbe Elektromedizin Gmbh, Utah Medical Products, Inc., Baisheng Medical Co., Ltd., Xodus Medical Inc. And Eakin Surgical among others.
The global patient return electrodes market report would provide approximately 61 tables, 57 figures and 182 pages.
LIST NOT EXHAUSTIVE